Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Keeley, Ellen C ^a,b   Moorman, J Randall ^a,b   Liu, Ling ^a,b   Gimple, Lawrence W ^a,b   Lipson, Lewis C ^a,b   Ragosta, Michael ^a,b   Taylor, Angela M ^a,b   Lake, Douglas E ^a,b   Burdick, Marie D ^b   Mehrad, Borna ^b   Strieter, Robert M ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RENTROP SCORING SYSTEM; SCORING SYSTEM; BLOOD; CHRONIC DISEASE; COLLATERAL CIRCULATION; CORONARY BLOOD VESSEL; HEART MUSCLE ISCHEMIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY;

CHEMOKINES; CHRONIC DISEASE; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA;

EID: 79959395141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021174     Document Type: Article

References (48)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, et al. (2008) Heart disease and stroke statistics-008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-146.
2. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, et al. (2009) Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol 132: 257-262.
3. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, et al. (1989) Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 79: 791-796.
4. Kodama K, Kusuoka H, Sakai A, Adachi T, Hasegawa S, et al. (1996) Collateral channels that develop after an acute myocardial infarction prevent subsequent left ventricular dilation. J Am Coll Cardiol 27: 1133-1139.
5. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, et al. (1991) Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 83: 739-746.
6. Elsman P, van 't Hof AW, de Boer MJ, Hoorntje JC, Suryapranata H, et al. (2004) Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J 25: 854-858.
7. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, et al. (2005) Comparison of the cardioprotective effect of prodromal angina pectoris and collateral circulation in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 95: 622-625.
8. Desch S, de Waha S, Eitel I, Koch A, Gutberlet M, et al. (2010) Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction. Am J Cardiol 106: 605-611.
9. Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y, (2005) Prognostic significance of coronary collaterals in patients with coronary heart disease having percutaneous transluminal coronary angioplasty. Am J Cardiol 96: 390-394.
10. Abbott JD, Choi EJ, Selzer F, Srinivas VS, Williams DO, (2005) Impact of coronary collaterals on outcome following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 96: 676-680.
11. Nathoe HM, Buskens E, Jansen EW, Suyker WJ, Stella PR, et al. (2004) Role of coronary collaterals in off-pump and on-pump coronary bypass surgery. Circulation 110: 1738-1742.
12. Nathoe HM, Koerselman J, Buskens E, van Dijk D, Stella PR, et al. (2006) Determinants and prognostic significance of collaterals in patients undergoing coronary revascularization. Am J Cardiol 98: 31-35.
13. Caputo M, Anis RR, Rogers CA, Ahmad N, Rizvi SI, et al. (2008) Coronary collateral circulation: effect on early and midterm outcomes after off-pump coronary artery bypass surgery. Ann Thorac Surg 85: 71-79.
14. Billinger M, Kloos P, Eberli FR, Windecker S, Meier B, et al. (2002) Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J Am Coll Cardiol 40: 1545-1550.
15. Seiler C, (2010) The human coronary collateral circulation. Eur J Clin Invest 40: 465-476.
16. Koerselman J, van der Graaf Y, de Jaegere PP, Grobbee DE, (2003) Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 107: 2507-2511.
17. Briguori C, Testa U, Colombo A, Petrucci E, Condorelli G, et al. (2006) Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol 97: 472-476.
18. Fleisch M, Billinger M, Eberli FR, Garachemani AR, Meier B, et al. (1999) Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 100: 1945-1950.
19. Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, et al. (2004) Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 43: 1383-1387.
20. Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M, (2006) Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 98: 1194-1197.
21. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, et al. (2004) Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 110: 1940-1945.
22. Keeley EC, Mehrad B, Strieter RM, (2008) Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 28: 1928-1936.
23. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357.
24. Levin DC, (1974) Pathways and functional significance of the coronary collateral circulation. Circulation 50: 831-837.
25. Rentrop KP, Cohen M, Blanke H, Phillips RA, (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5: 587-592.
26. van Liebergen RA, Piek JJ, Koch KT, de Winter RJ, Schotborgh CE, et al. (1999) Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables. J Am Coll Cardiol 33: 670-677.
27. Piek JJ, van Liebergen RA, Koch KT, Peters RJ, David GK, (1997) Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 29: 275-282.
28. Berry C, Balachandran KP, L'Allier PL, Lesperance J, Bonan R, et al. (2007) Importance of collateral circulation in coronary heart disease. Eur Heart J 28: 278-291.
29. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, et al. (2007) Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 116: 975-983.
30. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, et al. (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239-2242.
31. Kornowski R, (2003) Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 14: 61-64.
32. Nisanci Y, Sezer M, Umman B, Yilmaz E, Mercanoglu S, et al. (2002) Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement. J Invasive Cardiol 14: 118-122.
33. Nurkalem Z, Gorgulu S, Uslu N, Alper AT, Orhan AL, et al. (2008) Effect of glucometabolic disorders on the formation of coronary collaterals in occlusive coronary artery disease. Acta Cardiol 63: 141-146.
34. Waltenberger J, (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560.
35. Cohen M, Sherman W, Rentrop KP, Gorlin R, (1989) Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 13: 297-303.
36. Mason MJ, Walker SK, Patel DJ, Paul VE, Ilsley CD, (2000) Influence of clinical and angiographic factors on development of collateral channels. Coron Artery Dis 11: 573-578.
37. Olijhoek JK, Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, et al. (2005) Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease. Diabetes Care 28: 683-689.
38. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, et al. (2001) Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 38: 1872-1878.
39. Zbinden R, Zbinden S, Billinger M, Windecker S, Meier B, et al. (2005) Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart 91: 1289-1293.
40. Dincer I, Ongun A, Turhan S, Ozdol C, Kumbasar D, et al. (2006) Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis 17: 561-565.
41. Pourati I, Kimmelstiel C, Rand W, Karas RH, (2003) Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J 146: 876-881.
42. Hughes GC, Annex BH, (2005) Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Rev Cardiovasc Ther 3: 521-535.
43. Chung NA, Lydakis C, Belgore F, Li-Saw-Hee FL, Blann AD, et al. (2003) Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart 89: 1411-1415.
44. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, et al. (1999) Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100: 547-552.
45. Lakshminarayanan V, Lewallen M, Frangogiannis NG, Evans AJ, Wedin KE, et al. (2001) Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol 159: 1301-1311.
46. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, et al. (2000) IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101: 1519-1526.
47. Damas JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, et al. (2000) Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res 47: 778-787.
48. Ardigo D, Assimes TL, Fortmann SP, Go AS, Hlatky M, et al. (2007) Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 31: 402-409.